AU773329B2 - Materials and methods relating to disease diagnosis - Google Patents

Materials and methods relating to disease diagnosis Download PDF

Info

Publication number
AU773329B2
AU773329B2 AU49208/00A AU4920800A AU773329B2 AU 773329 B2 AU773329 B2 AU 773329B2 AU 49208/00 A AU49208/00 A AU 49208/00A AU 4920800 A AU4920800 A AU 4920800A AU 773329 B2 AU773329 B2 AU 773329B2
Authority
AU
Australia
Prior art keywords
disease
cells
characteristic
gene expression
tumour
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU49208/00A
Other languages
English (en)
Other versions
AU4920800A (en
Inventor
Alaiya Ayodele
Bo Franzen
Anders Hagman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PROTEOMEDICA AB
Original Assignee
PROTEOMEDICA AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PROTEOMEDICA AB filed Critical PROTEOMEDICA AB
Publication of AU4920800A publication Critical patent/AU4920800A/en
Assigned to PROTEOMEDICA AB reassignment PROTEOMEDICA AB Alteration of Name(s) of Applicant(s) under S113 Assignors: KAROLINSKA INNOVATIONS AB
Application granted granted Critical
Publication of AU773329B2 publication Critical patent/AU773329B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2550/00—Electrophoretic profiling, e.g. for proteome analysis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU49208/00A 1999-05-14 2000-05-11 Materials and methods relating to disease diagnosis Ceased AU773329B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13435699P 1999-05-14 1999-05-14
US60/134356 1999-05-14
PCT/EP2000/004265 WO2000070340A2 (fr) 1999-05-14 2000-05-11 Materiaux et procedes se rapportant au diagnostic de maladie

Publications (2)

Publication Number Publication Date
AU4920800A AU4920800A (en) 2000-12-05
AU773329B2 true AU773329B2 (en) 2004-05-20

Family

ID=22462994

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49208/00A Ceased AU773329B2 (en) 1999-05-14 2000-05-11 Materials and methods relating to disease diagnosis

Country Status (3)

Country Link
EP (1) EP1179175A2 (fr)
AU (1) AU773329B2 (fr)
WO (1) WO2000070340A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002543394A (ja) * 1999-04-26 2002-12-17 サーロメッド・インコーポレーテッド 表現型および生物学上のマーカーの同定系
US7567870B1 (en) 2000-07-31 2009-07-28 Institute For Systems Biology Multiparameter analysis for predictive medicine
WO2002010456A2 (fr) * 2000-07-31 2002-02-07 The Institute For Systems Biology Analyse a parametres multiples en medecine predictive
US7343247B2 (en) 2001-07-30 2008-03-11 The Institute For Systems Biology Methods of classifying drug responsiveness using multiparameter analysis
EP1319954A1 (fr) * 2001-12-12 2003-06-18 Centre National de Genotypage Methodes d'analyse des protéines qui utilisent des reseaux de capture
AU2003220998A1 (en) * 2002-04-04 2003-10-20 Ishihara Sangyo Kaisha, Ltd. Apparatus and method for analyzing data
US7464835B2 (en) 2002-12-19 2008-12-16 Braun Gmbh Preparing and dispensing mixed beverages
AT414171B (de) * 2002-12-19 2006-09-15 Red Bull Gmbh Verfahren zur diagnose des down-syndroms
AU2003901196A0 (en) * 2003-03-17 2003-04-03 Commonwealth Scientific And Industrial Research Organisation Analysis method
US20060263783A1 (en) * 2003-07-03 2006-11-23 Podhajcer Osvaldo L Methods and systems for diagnosis of non-central nervous system (cns) diseases in cns samples
AT500564B1 (de) * 2003-12-30 2006-02-15 Red Bull Gmbh Verfahren zur tumordiagnose
AT413542B (de) * 2003-12-30 2006-03-15 Red Bull Gmbh Diagnostizierung angeborener stoffwechselanomalien
EP1851332A4 (fr) * 2005-01-21 2010-05-26 Gene Express Inc Procedes et compositions pour evaluer des acides nucleiques
US10762982B1 (en) * 2015-10-07 2020-09-01 Trace Genomics, Inc. System and method for nucleotide analysis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020124A2 (fr) * 1996-10-25 1998-05-14 Peter Mose Larsen Proteines mediatrices du diabete et leurs utilisations therapeutiques
WO1998053319A2 (fr) * 1997-05-21 1998-11-26 The Johns Hopkins University Profils d'expression de genes dans des cellules normales et cancereuses

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5426029A (en) * 1986-03-31 1995-06-20 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using leukocyte surface antigens
ATE132269T1 (de) * 1990-11-30 1996-01-15 Monoclonetics Int Verfahren zur diagnose chronischer niedriger rückenschmerzen und nackenschmerzen
US5492547B1 (en) * 1993-09-14 1998-06-30 Dekalb Genetics Corp Process for predicting the phenotypic trait of yield in maize
US6022683A (en) * 1996-12-16 2000-02-08 Nova Molecular Inc. Methods for assessing the prognosis of a patient with a neurodegenerative disease
US5635365A (en) * 1995-08-07 1997-06-03 Emory University Noninvasive diagnosis for allograft rejection
US6156502A (en) * 1995-12-21 2000-12-05 Beattie; Kenneth Loren Arbitrary sequence oligonucleotide fingerprinting
JP2000510949A (ja) * 1996-04-26 2000-08-22 チルドレンズ メディカル センター コーポレーション 組織のリモデリングに関連した状態のための非観血的酵素スクリーン
CA2311239C (fr) * 1997-12-12 2004-03-16 The Regents Of The University Of California Methodes de definition de types cellulaires
ATE347102T1 (de) * 1998-02-25 2006-12-15 Us Health Zellulare anordnungen für schnelle molekulare profilidentifizierung
ATE253126T1 (de) * 1998-08-25 2003-11-15 Univ Washington Schnelle quantitative analyse von proteinen oder proteinfunktionen in komplexen gemischen
EP1133523A1 (fr) * 1998-11-16 2001-09-19 Genway Biotech, Inc. Generation d'anticorps par vaccination polynucleotidique dans le cas d'une espece aviaire
MXPA01007325A (es) * 1999-01-21 2002-06-04 Pioneer Hi Bred Int Perfilado molecular para la seleccion de la heterosis.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020124A2 (fr) * 1996-10-25 1998-05-14 Peter Mose Larsen Proteines mediatrices du diabete et leurs utilisations therapeutiques
WO1998053319A2 (fr) * 1997-05-21 1998-11-26 The Johns Hopkins University Profils d'expression de genes dans des cellules normales et cancereuses

Also Published As

Publication number Publication date
WO2000070340A3 (fr) 2001-02-08
WO2000070340A2 (fr) 2000-11-23
AU4920800A (en) 2000-12-05
EP1179175A2 (fr) 2002-02-13

Similar Documents

Publication Publication Date Title
Somiari et al. Proteomics of breast carcinoma
Wulfkuhle et al. Proteomic approaches to the diagnosis, treatment, and monitoring of cancer
Wulfkuhle et al. Proteomic applications for the early detection of cancer
Simone et al. Laser capture microdissection: beyond functional genomics to proteomics
Ardekani et al. Clinical potential of proteomics in the diagnosis of ovarian cancer
AU773329B2 (en) Materials and methods relating to disease diagnosis
Shi et al. Protein extraction from formalin-fixed, paraffin-embedded tissue sections: quality evaluation by mass spectrometry
Chuaqui et al. Post-analysis follow-up and validation of microarray experiments
Alaiya et al. Clinical cancer proteomics: promises and pitfalls
AU772680B2 (en) LCM (Laser capture microdissection) for cellular protein analysis
Kampf et al. Antibody-based tissue profiling as a tool for clinical proteomics
EP1891433B1 (fr) Procédé de classification d'échantillons cellulaires chimiquement réticulés par spectre de masse
Bandera et al. New technologies for the identification of markers for early detection of ovarian cancer
CN105368925B (zh) 用于肺癌预后的生物标志物及其用途
Alaiya et al. Classification of human ovarian tumors using multivariate data analysis of polypeptide expression patterns
Sabel et al. Proteomics in melanoma biomarker discovery: great potential, many obstacles
US20050100967A1 (en) Detection of endometrial pathology
Meyer et al. High‐performance proteomics as a tool in biomarker discovery
CN115128285A (zh) 一种蛋白质组合对甲状腺滤泡性肿瘤鉴别评估的试剂盒、系统
Jain Role of proteomics in diagnosis of cancer
Nambiar et al. Global gene expression profiling: a complement to conventional histopathologic analysis of neoplasia
Steinert et al. Proteomic prediction of disease outcome in cancer: clinical framework and current status
CN113718032B (zh) 生物标志物在早期检测宫颈癌中的应用
Keesee Molecular diagnostics: impact upon cancer detection
Shoshan et al. Proteomics in clinical laboratory diagnosis

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: PROTEOMEDICA AB

Free format text: THE FORMER OWNER WAS: KAROLINSKA INNOVATIONS AB

FGA Letters patent sealed or granted (standard patent)